Olanzapine

Imran Qureshi, PharmD, BCPP

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Schizophrenia
  • Manic or mixed episodes associated with bipolar I disorder with or without lithium or valproic acid
  • Maintenance treatment of bipolar I disorder
  • Bipolar I depression (olanzapine/fluoxetine)
  • Treatment-resistant depression (olanzapine/fluoxetine)
  • Agitation associated with schizophrenia or bipolar I mania (IM)

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Management of delirium
  • Nausea and vomiting
  • Anorexia nervosa

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.